CytRx Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
47,485.40
30,118.00
58,587.20
50,771.20
34,986.40
9,079.40
Depreciation, Depletion & Amortization
120.40
182.90
317.60
536.60
629.30
29.40
Other Funds
24,079.40
12,579.40
7,449.60
3,508.10
4,324.60
52.30
Funds from Operations
23,285.70
42,514.50
50,819.90
46,726.50
30,032.50
8,997.70
Changes in Working Capital
465.30
1,958.70
3,237.50
3,123.80
2,834.90
1,869.80
Net Operating Cash Flow
23,751.00
40,555.80
47,582.40
49,850.40
27,197.60
10,867.50
Capital Expenditures
41.80
956.30
331.30
1,020.40
134.60
Purchase/Sale of Investments
3,085.00
18,536.60
10,586.20
35,035.40
-
Net Investing Cash Flow
3,126.80
19,492.90
10,254.80
34,015.00
134.60
Issuance/Reduction of Debt, Net
-
-
-
24,012.10
15,213.60
Net Financing Cash Flow
24,016.80
80,784.50
27,370.10
50,533.50
8,016.10
Net Change in Cash
2,861.00
20,735.80
9,957.50
34,698.10
19,316.10
Free Cash Flow
23,792.80
41,512.10
47,913.80
50,870.80
27,332.20
Change in Capital Stock
24,016.80
80,784.50
27,370.10
26,521.40
23,229.70
About CytRx
View Profile
